PMID: 6107263Jul 1, 1980Paper

Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine

Gut
P A van HeesJ H van Tongeren

Abstract

Suppositories of sulphapyridine, 5-aminosalicylic acid, and placebo were used in 45 patients with idiopathic proctitis to determine the active part of sulphasalazine. Each patient used one of the suppositories twice daily for four weeks in a double-blind controlled trial. Complete clinical remission with normal rectal mucosa on sigmoidoscopy occurred in 60% of patients given 5-aminosalicylic acid, but in only 13% and 27% of those given sulphapyridine and placebo respectively. Twelve patients were included twice. In eight of these patients 5-aminosalicylic acid was given one time and sulphapyridine (two patients) or placebo (six patients) another time. Clinical remission occurred in each patient with 5-aminosalicylic acid, but in only one patient during other therapy. The results suggest that 5-aminosalicylic acid is the active therapeutic moiety of sulphasalazine.

References

Feb 28, 1973·Clinica Chimica Acta; International Journal of Clinical Chemistry·U W KerstenS Agoston
Jun 11, 1970·The New England Journal of Medicine·J H Folley
Apr 11, 1959·British Medical Journal·S C TRUELOVE
Sep 1, 1962·Gut·J E LENNARD-JONESF A JONES
Jan 11, 1964·British Medical Journal·J H BARONJ E LENNARD-JONES

❮ Previous
Next ❯

Citations

Mar 12, 2010·Inflammatory Bowel Diseases·Kan UchiyamaHisao Tajiri
Jun 1, 1984·Naunyn-Schmiedeberg's Archives of Pharmacology·U DienerU Klotz
Sep 1, 1992·Digestive Diseases and Sciences·M B GrishamI S Sandhu
Oct 1, 1993·Digestive Diseases and Sciences·J P WrightK Jaskiewicz
Jul 1, 1987·Digestive Diseases and Sciences·J GandolfoM Kaplan
Sep 1, 1983·Digestive Diseases and Sciences·S L Taffet, K M Das
Jul 1, 1983·Digestive Diseases and Sciences·R P ChanJ E Lennard-Jones
Dec 1, 1987·Digestive Diseases and Sciences·U Klotz, K E Maier
Dec 1, 1987·Digestive Diseases and Sciences·M CampieriL Barbara
Dec 1, 1987·Digestive Diseases and Sciences·M S McPheeN J Greenberger
Apr 1, 1989·Digestive Diseases and Sciences·M B Grisham, D N Granger
Mar 1, 1988·Digestive Diseases and Sciences·L C Karp, S R Targan
Nov 1, 1989·Digestive Diseases and Sciences·B E Greenwell
Feb 1, 1989·Diseases of the Colon and Rectum·F NagyV Varro
Jan 1, 1987·European Journal of Drug Metabolism and Pharmacokinetics·M Ryde, S Gustavsson
Apr 7, 2005·Digestive Diseases and Sciences·Douglas C McVeySteven R Vigna
Nov 1, 1987·Biochemical Pharmacology·B J DullP Goldman
Nov 1, 1990·Immunopharmacology·F ShanahanP Anton
Mar 1, 1992·Baillière's Clinical Gastroenterology·R J Polson, J J Misiewicz
May 17, 2005·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·U Klotz
Feb 1, 1996·The American Journal of Medicine·G M WilcoxE G Galvanek
Nov 21, 1981·Lancet·P C O'ConnorS Madsen
Nov 21, 1981·Lancet·D P Jewell, S C Truelove
Feb 1, 1997·Journal of Hepatology·B StoschusT Sauerbruch
Nov 21, 1998·Journal of Chromatography. B, Biomedical Sciences and Applications·F N HussainS A Riley
Oct 16, 2001·Journal of Pharmaceutical and Biomedical Analysis·B NigovićI Fistrić
May 16, 2002·International Immunopharmacology·Shunsei HirohataKaori Aramaki
Jan 28, 2003·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·P PaoluziS Ardizzone
Feb 18, 1982·The New England Journal of Medicine·A G SchwartzW M Weinstein
Apr 1, 1982·The New England Journal of Medicine·J B Kirsner, R G Shorter

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.